FreeTheAI

XORTX Therapeutics, Inc.

XRTX · NASDAQ · USD

$1.41

−0.44 −23.78%todayNot financial advice.

XRTX Price chart 5D
Open
2.05
Day range
1.36 - 2.08
52-week range
1.36 - 7.05
Volume
18.65M
Market cap
2.56M
P/E ratio
—
EPS
-2.74
Dividend yield
0.00%
Beta
0.51

Performance

W

−17.88%

1M

−37.61%

3M

−33.02%

6M

−37.33%

YTD

−50.45%

Y

−69.24%

5Y

−99.08%

All

−99.08%

In the news

  1. Oct 8

    XORTX Therapeutics Outlines Plan to File Canadian Clinical Trial Application for Gout Drug XORLO

    XORTX Therapeutics plans to submit a Clinical Trial Application in Canada for its gout treatment XORLO to accelerate its regulatory pathway to the FDA.

    Company news

  2. Oct 8

    XORTX Therapeutics Plans Clinical Trial Application in Canada for Gout Drug XORLO

    XORTX Therapeutics plans to file a clinical trial application in Canada for its gout treatment XORLO to accelerate its planned FDA approval pathway.

    Company news

Embed on your site

Embed docs

Add a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.

<iframe src="https://stocks.freetheai.org/embed/NASDAQ-XRTX" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="XORTX Therapeutics, Inc. (XRTX) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-XRTX">XRTX stock price</a> by FreeTheAI Stocks</p>